XDx Secures $6M Debt
XDx, the Brisbane, CA-based developer of molecular diagnostics, has secured $6 million through a debt and options financing that could ultimately be worth $10 million, according to a regulatory filing. The company, founded in 2000, raised $14 million in August 2009 from a long list of backers, including Bristol-Myers Squibb, Burrill Venture Capital, Intel Capital, Kleiner Perkins Caufield & Byers, and TPG Biotechnology. The plan, stated in that announcement, was for XDx to break even in 2010. A spokesperson for the company didn’t immediately respond to a request for comment about the new debt financing.